-

SMPL INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving The Simply Good Foods Company

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of The Simply Good Foods Company (“Simply Good Foods” or the “Company”) (NASDAQ:SMPL) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

[LEARN MORE ABOUT THE INVESTIGATION]

What Happened?

On April 9, 2026, Simply Good Foods reported its financial results and updated its outlook. Among other things, the Company stated that its net sales performance was “largely driven by poor retail takeaway,” that Quest consumption was affected by “slower base velocity in chips and bars,” and that its “recent results have not met [its] expectations.” The Company also reduced its full-year guidance, forecasting net sales to decline approximately 10% to 7% year-over-year and adjusted EBITDA to decline approximately 22% to 19%. In addition, Simply Good Foods disclosed a non-cash impairment charge of approximately $249 million, which the Company attributed largely to “updated projections of future revenue.” On this news, the price of Simply Good Foods shares declined by $2.61 per share, or approximately 18.1%, from $14.41 per share on April 8, 2026 to close at $11.80 on April 9, 2026.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired Simply Good Foods securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:SMPL

Release Versions

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

OMF INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving OneMain Holdings, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE:OMF) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 16, 2026, New York Attorney General Letitia James, along with a coalition of 12 other state attorney gene...

EQPT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving EquipmentShare, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of EquipmentShare, Inc. (“EquipmentShare” or the “Company”) (NASDAQ:EQPT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On March 18, 2026, after the market closed, EquipmentShare reported financial results that revealed the ma...

REMINDER: Atara Biotherapeutics, Inc. Investors With Significant Losses Must Act By May 22, 2026 – Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ:ATRA) investors of the May 22, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors a...
Back to Newsroom